- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Recombinant human apolipoprotein A-I in a complex with phosp
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Recombinant human apolipoprotein A-I in a complex with phospholipids
| EU orphan designation number: | EU/3/14/1315
|
| Active ingredient: | Recombinant human apolipoprotein A-I in a complex with phospholipids |
| Indication: | Treatment of apolipoprotein A-I deficiency |
| Sponsor: | Cerenis Therapeutics Holding SA
265 rue de la Découverte, Bât. A, 31670 Labege, France |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 26/08/2014 | Orphan designation | EMA/OD/064/14 | (2014)6121 of 22/08/2014 |
CONTACT
EU links
Directorate General Health & Consumers